Resistance to inhibitors of the human immunodeficiency virus type 1 integration

21Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the fi rst integrase inhibitor licensed to treat HIV-1 infection. ©Elsevier Editora Ltda.

Cite

CITATION STYLE

APA

Hazuda, D. J. (2010). Resistance to inhibitors of the human immunodeficiency virus type 1 integration. Brazilian Journal of Infectious Diseases. Elsevier Editora Ltda. https://doi.org/10.1016/s1413-8670(10)70103-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free